Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

(Image credit: ©Hand Robot/AdobeStock) Kriya Therapeutics reported in an SEC filing it has raised $313.3 million in a recent funding round.1 The filing does not detail fund specificity or funding sources but rather only states two investors participated in the…

Vivienne S. Hau, MD, PhD, a vitreoretinal surgeon and faculty member at the Bernard J Tyson School of Medicine, Kaiser Permanente Med School, and also at the California University of School of Medicine, presented research on racial and ethnic disparities…

(Image credit: AdobeStock/marchsirawit) When propofol is used to sedate patients and during periocular injection, the stage may be set for a sneeze reflex, an unexpected movement that can cause needle injury to the globe or optic nerve or a hematoma.…
Advances in Neovascular Macular Degeneration From ASRS 2025 Medscape Source: Author: | Date: 2025-08-22 18:49:00 Source: Author: | Date: 2025-08-22 18:49:00
2-day ‘Eye-Conic’ conference kicks off in Chandigarh today The Times of India Source: Author: | Date: 2025-08-22 18:39:00 Source: Author: | Date: 2025-08-22 18:39:00

Sally S. Ong, MD, an assistant professor of ophthalmology at Atrium Health Wake Forest Baptist School of Medicine, presented research examining the relationship between neighborhood-level social determinants of health and disease severity in patients with tractional retinal detachments (TRD) associated…

(Image credit: AdobeStock/Drazen) K. Chalam MD, PhD, MBA, FRCS(C), FASRS, presented, “Dropless vitrectomy with suprachoroidal triamcinolone-moxifloxacin: A comparative analysis of safety and efficacy with standard-of-care topical drops” at the 2025 annual scientific meeting of the American Society of Retina Specialists.…

(Image Credit: AdobeStock/ME Image) Tear trough filler remains a topic of debate among some surgeons due to concerns about complications such as edema, malar mound accentuation, and vascular compromise. Nonetheless, this treatment has continuously proven to be an effective tool…
Oculis’ Advancing Pipeline and Financial Strength Position It as a High-Potential Biopharma Play in Ophthalmology and Neuro-Ophthalmology AInvest Source: Author: | Date: 2025-08-22 09:11:00 Source: Author: | Date: 2025-08-22 09:11:00
Safety and effect of topical neostigmine ophthalmic solution in animal models | Scientific Reports Nature Source: Author: | Date: 2025-08-22 06:16:00 Source: Author: | Date: 2025-08-22 06:16:00